Kashiv Biosciences Profile
Key Indicators
- Authorised Capital ₹ 117.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 99.05 Cr
as on 13-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 114.25%
(FY 2021)
- Profit 84.97%
(FY 2021)
- Ebitda 138.09%
(FY 2021)
- Net Worth 10.76%
(FY 2021)
- Total Assets 4.95%
(FY 2021)
About Kashiv Biosciences
The Corporate was formerly known as Adello Biologics Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 117.00 Cr and a paid-up capital of Rs 99.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kashiv Biosciences Private Limited India is Nirali Thula as COMPANY SECRETARY. Chinubhai Patel and Suresh Patel serve as directors at the Company.
- CIN/LLPIN
U74995GJ2018FTC103064
- Company No.
103064
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
29 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kashiv Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirali Thula  | Company Secretary | 25-Nov-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chinubhai Patel | Director | 29-Sep-2020 | Current |
| Suresh Patel | Director | 29-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Kashiv Biosciences.
Kashiv Biosciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 114.25% increase. The company also saw a substantial improvement in profitability, with a 84.97% increase in profit. The company's net worth Soared by an impressive increase of 10.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kashiv Biosciences?
In 2022, Kashiv Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivanka Research Private LimitedActive 1 year 3 monthsChinubhai Patel and Suresh Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kashiv Biosciences?
Kashiv Biosciences has a workforce of 164 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kashiv Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kashiv Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
